ClinicalTrials.gg
CompletedNCT05261074COCEUpdated Nov 6, 2026

Foreign Body Ingestion During COVID-19 Lockdown

An observational study in Foreign Body Ingestion, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 1 Day to 15 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Updated Nov 6, 2026Now CompletedEnrollment updatedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
1 Day to 15 Years
Sex
All
01

Study summary

Ingestion of foreign bodies (FB) is one of the most observed domestic accidents and a frequent reason for consultation in pediatric emergency departments (PED). In the United States, nearly 100,000 ingestions of FB have been recorded by the National Poison Data System (NPDS), which represented the 4th cause of intoxication in 2015.

Ingestion of FB involves very different mechanisms in children and adult patients. Unlike adults, 98% of FB ingestions in children are accidental and involve common objects found at home environment. Ingested FBs are of many types and vary depending on the object composition of the child's environment and supervision. The lockdown for COVID-19 pandemic highly modified children environment and parent supervision. Children remained at home and parents lived at home for teleworking.

In this study, the modifications of children environment that could affect epidemiology of FB ingestion will be evaluated. This is a retrospective study with a sample of around > 100 children of Louis Mourier hospital from January 1 to December 31, 2019 and from March 1 to May 31, 2020. The total duration of the study is planned for 10 months.

Primary outcomes:

  • To determine the role of COVID-19 pandemic linked containment on the prevalence of FB ingestions in children.

Secondary outcomes:

  • Describe the epidemiological-clinical, radiological, therapeutic and evolutionary characteristics of the FB consultant's ingestions in the emergency department
  • Determine the frequency of endoscopy or surgery
  • Determine the factors favoring the use of endoscopic extraction From March 16 to May 10, 2020.
Read the detailed description

To analyze the impact of COVID-19 lockdown in 2020 on FB ingestion by children, to compare epidemiology of FB ingestion during 3 periods: 2020 lockdown (March to May 2020), the entire 2019 year and March to May 2019. The anonymized data will be entered in Epidata software and data transfer secured using APHP servers.

The variables of interest will include: sex, age at the time of ingestion, type of the FB, single or multiple ingestion, annual period of ingestion, ingestion schedule, existence of a witness, time of arrival at the emergency room, presence and nature of clinical symptoms of ingestion, position of the FB in the digestive tract, complications of this ingestion, x-ray exams used to locate FB need for an extraction gesture, nature of this gesture, completion time, successes and complications of extraction.

The population should have an estimated number of between 100-150 children. Descriptive statistics. The quantitative variables will be described as mean and standard deviation or as median, quartiles, minimum and maximum depending on whether their distribution is Gaussian or not. The qualitative variables will be described in numbers (percentage).

Comparison tests. Qualitative data will be analyzed using Chi2 or Fischer's exact test.

The study was approved by hospital's ethics committee.

02

Conditions studied

  • Foreign Body Ingestion

Keywords

  • Foreign body
  • Children
  • Covid-19
  • Oesophagus
03

In context

Foreign Bodies

29 studies on the registry are indexed under Foreign Bodies; 8 are open to participants now.

This study's enrollment of 100 is close to the median of 100 across 19 observational studies indexed under Foreign Bodies.

Browse Foreign Bodies studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 15 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Child who consulted in the pediatric emergency department of Louis-Mourier University Hospital for ingestion of foreign bodies coded in Urqual software.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children \<15 years old.
  • Child who consulted in the pediatric emergency department of Louis-Mourier University Hospital.
  • For ingestion of foreign bodies coded in Urqual software.

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study
  • unusable files (> 20% missing data out of a total of 40 major items),
  • Ingestion of CE was suspected but not confirmed,
  • Ingestion of caustics or other chemicals,
  • Introduced from an FB into the digestive tract by a route other than the oral cavity.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (actual)
Patient registry
No

Interventions

  • OtherNo intervention

    No intervention (retrospective study)

06

What researchers measure

Primary outcomes

  1. Prevalence of foreign body (FB) ingestions in children

    To determine the role of COVID-19 pandemic linked containment on the prevalence of foreign body (FB) ingestions in children

    Time frame: 1 year

07

Study locations

1 site
  • Louis Mourier Hospital - Assistance Publique Hopitaux de Paris
    Colombes, 92025, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Status unknown→Completed
changed Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Status unknown→Completed
    + 5 other changes: verification date, date precision, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05261074
Responsible party
Sponsor
First posted
Mar 2, 2022
Start date
Oct 20, 2021
Primary completion
Oct 20, 2022
Completion
Oct 20, 2022
Last update
Nov 6, 2026

Study contacts

Jerôme VIALA, MD, PhD
study chair · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion